No photo of Gregory A Grandits
Contact Expert

View Scopus Profile

Gregory A Grandits

1984 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Adjunct vitamin D therapy as a means to reduce the dispa

Grandits, G. A.

Wayne State University

12/1/15 → 6/30/16

Project: Research project

    • Analytical support for Project Phidisa

    Grandits, G. A.

    THE HENRY M. JACKSON FOUNDATION

    4/1/14 → 9/30/15

    Project: Research project

    Adjunct vitamin D therapy as a means to reduce the dispa

    Grandits, G. A.

    Wayne State University

    7/1/11 → 11/30/15

    Project: Research project

    • Infectious Disease Clinical Research Program - Data Anal

    Eberly, L. E., Grandits, G. A. & Lifson, A. R.

    THE HENRY M. JACKSON FOUNDATION

    5/23/07 → 3/31/12

    Project: Research project

    • Research Output

    Early cardiovascular structural and functional abnormalities as a guide to future morbid events

    Duprez, D. A., Duval, S., Hoke, L., Florea, N., Grandits, G., Carlson, C., Lee, J. & Cohn, J. N., Jan 1 2020, (Accepted/In press) In : European Journal of Preventive Cardiology.

    Research output: Contribution to journal › Article

    • 3 Scopus citations

    PreVail I cluster vaccination study with RVSVDG-Zebov-GP as part of a public health response in Liberia

    Bolay, F. K., Grandits, G., Clifford Lane, H., Kennedy, S. B., Johnson, M. P., Fallah, M. P., Wilson, B., Njoh, W. S., McNay, L. A., Hensley, L. E. & Higgs, E. S., May 1 2019, In : Journal of Infectious Diseases. 219, 10, p. 1634-1641 8 p.

    Research output: Contribution to journal › Article

    Open Access

    • World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

    Kaptoge, S., Pennells, L., De Bacquer, D., Cooney, M. T., Kavousi, M., Stevens, G., Riley, L. M., Savin, S., Khan, T., Altay, S., Amouyel, P., Assmann, G., Bell, S., Ben-Shlomo, Y., Berkman, L., Beulens, J. W., Björkelund, C., Blaha, M., Blazer, D. G., Bolton, T. & 81 others, Bonita Beaglehole, R., Brenner, H., Brunner, E. J., Casiglia, E., Chamnan, P., Choi, Y. H., Chowdry, R., Coady, S., Crespo, C. J., Cushman, M., Dagenais, G. R., D'Agostino, R. B., Daimon, M., Davidson, K. W., Engström, G., Ford, I., Gallacher, J., Gansevoort, R. T., Gaziano, T. A., Giampaoli, S., Grandits, G., Grimsgaard, S., Grobbee, D. E., Gudnason, V., Guo, Q., Tolonen, H., Humphries, S., Iso, H., Jukema, J. W., Kauhanen, J., Kengne, A. P., Khalili, D., Koenig, W., Kromhout, D., Krumholz, H., Lam, T. H., Laughlin, G., Marín Ibañez, A., Meade, T. W., Moons, K. G. M., Nietert, P. J., Ninomiya, T., Nordestgaard, B. G., O'Donnell, C., Palmieri, L., Patel, A., Perel, P., Price, J. F., Providencia, R., Ridker, P. M., Rodriguez, B., Rosengren, A., Roussel, R., Sakurai, M., Salomaa, V., Sato, S., Schöttker, B., Shara, N., Shaw, J. E., Shin, H. C., Simons, L. A., Sofianopoulou, E., Sundström, J., Völzke, H., Wallace, R. B., Wareham, N. J., Willeit, P., Wood, D., Wood, A., Zhao, D., Woodward, M., Danaei, G., Roth, G., Mendis, S., Onuma, O., Varghese, C., Ezzati, M., Graham, I., Jackson, R., Danesh, J. & Di Angelantonio, E., Oct 2019, In : The Lancet Global Health. 7, 10, p. e1332-e1345

    Research output: Contribution to journal › Article

    Open Access
    • 18 Scopus citations

    A review of strategies used to retain participants in clinical research during an infectious disease outbreak: The PREVAIL I Ebola vaccine trial experience

    Browne, S., Carter, T., Eckes, R., Grandits, G. A., Johnson, M., Moore, I. & McNay, L., Sep 2018, In : Contemporary Clinical Trials Communications. 11, p. 50-54 5 p.

    Research output: Contribution to journal › Article

    Open Access

    • Use of the Filovirus Animal Non-Clinical Group (FANG) Ebola virus immuno-assay requires fewer study participants to power a study than the Alpha Diagnostic International assay

    Logue, J., Tuznik, K., Follmann, D., Grandits, G., Marchand, J., Reilly, C., Sarro, Y. D. S., Pettitt, J., Stavale, E. J., Fallah, M., Olinger, G. G., Bolay, F. K. & Hensley, L. E., May 2018, In : Journal of Virological Methods. 255, p. 84-90 7 p.

    Research output: Contribution to journal › Article

    • 5 Scopus citations